tiprankstipranks
Mereo Biopharma (MREO)
NASDAQ:MREO
US Market
MREO
Mereo Biopharma Group Plc
RESEARCH TOOLSreports
Want to see MREO full AI Analyst Report?

Mereo Biopharma Group Plc (MREO) Income Statement

870 Followers

Mereo Biopharma Group Plc Income Statement

Last quarter (Q1 2026), Mereo Biopharma Group Plc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Mereo Biopharma Group Plc's net income was $-6.71M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 500.00K$ 0.00$ 10.00M$ 0.00$ 49.21M
Gross Profit
$ 367.00K$ 0.00$ 7.43M$ 257.44K$ 25.04M
Operating Expenses
$ 38.62M$ 47.36M$ 35.84M$ 53.92M$ 53.30M
Depreciation and Amortization
$ 1.15M$ 1.09M$ 1.06M$ 895.50K$ 866.47K
EBITDA
$ -40.47M$ -40.80M$ -26.06M$ -39.98M$ 25.49M
Operating Income
$ -38.26M$ -47.36M$ -28.42M$ -53.67M-
Other Income/Expenses
$ -3.62M$ 4.11M$ -1.58M$ 9.21M$ 47.48M
Pretax Income
$ -41.88M$ -43.25M$ -30.00M$ -44.46M$ 19.22M
Net Income
$ -41.88M$ -43.25M$ -29.47M$ -42.12M$ 17.17M
Per Share Metrics
Basic EPS
$ -0.26$ -0.29$ -1.10K$ -1.75K$ 749.65
Diluted EPS
$ -0.26$ -0.29$ -1.10K$ -1.75K$ 749.65
Weighted Average Shares Outstanding
 159.42M 147.92M 131.89M 120.64M 116.73M
Weighted Average Shares Outstanding (Diluted)
 159.42M 147.92M 131.89M 120.64M 116.73M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History